CRWRF logo

Craneware plc (CRWRF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, Craneware plc (CRWRF) es una empresa del sector Healthcare valorada en 0. La acción obtiene una puntuación de 50/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 50/100

Craneware plc (CRWRF) Resumen de Asistencia Médica y Tuberías

CEOKeith Neilson
Empleados747
Sede CentralEdinburgh, GB
Año de la oferta pública inicial (OPI)2012

Craneware plc delivers software solutions to enhance financial performance and operational efficiency for US healthcare providers, specializing in pricing transparency, revenue cycle management, and compliance. With a focus on data analytics and automation, Craneware addresses the complexities of healthcare finance, positioning itself as a key player in the healthcare information services sector.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Craneware plc presents a compelling investment case based on its established position in the healthcare information services market and its comprehensive suite of software solutions. The company's focus on pricing transparency, revenue cycle management, and regulatory compliance addresses critical needs for US healthcare providers. With a gross margin of 78.0% and a profit margin of 10.6%, Craneware demonstrates strong profitability. Key growth catalysts include the increasing complexity of healthcare finance and the growing demand for data-driven solutions. The company's beta of -0.36 suggests lower volatility compared to the market. However, investors may want to evaluate the risks associated with operating in a highly regulated industry and the potential for increased competition.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.85 billion indicates a significant presence in the healthcare information services market.
  • P/E ratio of 28.49 suggests a premium valuation, reflecting investor expectations for future growth.
  • Gross margin of 78.0% demonstrates strong pricing power and efficient cost management.
  • Profit margin of 10.6% indicates solid profitability in the competitive healthcare software market.
  • Dividend yield of 2.32% provides a steady income stream for investors.

Competidores y Pares

Fortalezas

  • Comprehensive suite of software solutions for healthcare providers.
  • Strong focus on pricing transparency and revenue cycle management.
  • Established customer base in the US healthcare market.
  • Deep expertise in healthcare regulations and compliance.

Debilidades

  • Reliance on the US healthcare market.
  • Potential for increased competition from larger technology companies.
  • Exposure to changes in healthcare regulations and reimbursement policies.
  • Limited brand recognition outside of the US.

Catalizadores

  • Ongoing: Continued adoption of value-based care models driving demand for Craneware's solutions.
  • Ongoing: Increasing complexity of healthcare regulations requiring advanced software solutions.
  • Upcoming: Potential acquisitions of complementary technologies to expand product portfolio.
  • Ongoing: Expansion of cloud-based offerings to meet evolving customer needs.
  • Upcoming: New product launches targeting emerging healthcare challenges in Q3 2026.

Riesgos

  • Potential: Changes in healthcare regulations and reimbursement policies impacting demand for Craneware's solutions.
  • Potential: Increased competition from larger technology companies entering the healthcare market.
  • Potential: Cybersecurity threats and data breaches compromising sensitive patient information.
  • Ongoing: Reliance on the US healthcare market exposing Craneware to economic and political risks.
  • Potential: Integration challenges associated with future acquisitions.

Oportunidades de crecimiento

  • Expansion of Trisus Platform: Craneware can expand its Trisus platform by integrating new modules and functionalities, such as advanced analytics and artificial intelligence, to provide more comprehensive solutions for healthcare providers. The market for AI in healthcare is projected to reach $34 billion by 2025, presenting a significant opportunity for Craneware to enhance its offerings and attract new customers.
  • Strategic Acquisitions: Craneware can pursue strategic acquisitions to expand its product portfolio and market reach. Acquiring companies with complementary technologies or customer bases can accelerate growth and strengthen Craneware's competitive position. The healthcare IT market is highly fragmented, offering numerous acquisition opportunities for Craneware to consolidate its presence.
  • Increased Focus on Cloud-Based Solutions: Craneware can capitalize on the growing demand for cloud-based solutions by migrating its existing software to the cloud and developing new cloud-native applications. Cloud-based solutions offer greater scalability, flexibility, and cost-effectiveness, making them increasingly attractive to healthcare providers. The global healthcare cloud computing market is expected to reach $55.6 billion by 2027.
  • Penetration of Smaller Healthcare Providers: Craneware can target smaller healthcare providers, such as community hospitals and physician practices, which may have limited access to advanced software solutions. By offering tailored solutions and flexible pricing models, Craneware can expand its customer base and increase its market share. The market for healthcare IT solutions among small and medium-sized providers is estimated to be worth $15 billion.
  • International Expansion: Craneware can explore opportunities to expand its operations into international markets, such as Europe and Asia, where there is a growing demand for healthcare IT solutions. By adapting its software to meet local regulations and market needs, Craneware can tap into new revenue streams and diversify its geographic footprint. The global healthcare IT market is projected to reach $390 billion by 2024.

Oportunidades

  • Expansion into new geographic markets.
  • Development of new software solutions for emerging healthcare needs.
  • Strategic acquisitions to expand product portfolio and market reach.
  • Increased adoption of cloud-based solutions in the healthcare industry.

Amenazas

  • Changes in healthcare regulations and reimbursement policies.
  • Increased competition from larger technology companies.
  • Cybersecurity threats and data breaches.
  • Economic downturn and reduced healthcare spending.

Ventajas competitivas

  • Proprietary technology: Craneware's software solutions are based on proprietary technology and algorithms.
  • Established customer base: The company has a large and established customer base in the US healthcare market.
  • Regulatory expertise: Craneware possesses deep expertise in healthcare regulations and compliance.
  • Data analytics capabilities: The company's solutions leverage data analytics to provide valuable insights to its customers.

Acerca de CRWRF

Craneware plc, established in 1999 and headquartered in Edinburgh, UK, develops, licenses, and supports computer software for the healthcare industry in the United States. The company's suite of solutions is designed to improve financial performance, ensure regulatory compliance, and enhance operational efficiency for healthcare providers. Craneware's offerings include Trisus pricing transparency software, which provides tools for price modeling and analysis; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, which assists with medical necessity compliance; and Trisus Claims Informatics, a retrospective charge capture analytical application. Further solutions include Trisus Supply, aimed at improving supplies reimbursement, and InSight Audit, an audit management solution. Craneware also offers InSight Denials for denial data analysis, Trisus Healthcare Intelligence for patient-level resource consumption insights, Trisus Medication Analytic solutions, and Trisus supplies assistant solutions. Additionally, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution for expanding medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution for pharmacy procurement and compliance. Craneware's comprehensive portfolio addresses critical needs in healthcare finance and operations, solidifying its position as a key player in the healthcare information services market.

Qué hacen

  • Develops and licenses computer software for the healthcare industry.
  • Provides solutions for pricing transparency and revenue cycle management.
  • Offers automated chargemaster management solutions.
  • Delivers medical necessity compliance solutions.
  • Provides retrospective charge capture analytical applications.
  • Offers drug tracking and medication access solutions.
  • Provides solutions for pharmacy procurement, utilization, and compliance.

Modelo de Negocio

  • Software licensing: Generates revenue through licensing its software solutions to healthcare providers.
  • Subscription services: Offers subscription-based access to its cloud-based solutions.
  • Professional services: Provides consulting, implementation, and training services to its customers.
  • Maintenance and support: Generates recurring revenue through maintenance and support contracts.

Contexto de la Industria

Craneware plc operates within the healthcare information services industry, a sector experiencing significant growth due to increasing regulatory complexity and the need for data-driven decision-making. The market is characterized by a mix of established players and emerging technology companies. Craneware's focus on pricing transparency and revenue cycle management positions it to capitalize on the growing demand for solutions that improve financial performance and compliance for healthcare providers. The industry is expected to continue growing as healthcare organizations seek to optimize operations and navigate evolving regulations.

Clientes Clave

  • Hospitals and healthcare systems: Provides solutions to improve financial performance and compliance.
  • Physician practices: Offers software to streamline revenue cycle management.
  • Government and commercial payors: Delivers audit management and claims analysis solutions.
Confianza de la IA: 73% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Craneware plc (CRWRF): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CRWRF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para CRWRF.

MoonshotScore

50/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de CRWRF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Keith Neilson

CEO

Keith Neilson is the CEO of Craneware plc. His background includes extensive experience in the healthcare technology sector. He has been instrumental in guiding Craneware's strategic direction and growth. Neilson's expertise spans software development, sales, and marketing within the healthcare IT landscape. His leadership is focused on driving innovation and delivering value to Craneware's customers through advanced software solutions.

Historial: Under Keith Neilson's leadership, Craneware has expanded its product portfolio and strengthened its position in the US healthcare market. Key achievements include the development and launch of the Trisus platform and the acquisition of key technologies to enhance Craneware's offerings. He has overseen the company's growth in revenue and profitability, solidifying its reputation as a leading provider of healthcare financial software.

Información del mercado OTC de CRWRF

The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for trading on OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, and there is no minimum financial standard required. This tier often includes shell companies, defunct companies, and companies with questionable business practices. Investing in OTC Other securities carries a significantly higher risk compared to securities traded on regulated exchanges like the NYSE or NASDAQ due to the lack of transparency and regulatory oversight.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for CRWRF on the OTC market is likely to be limited, with potentially wide bid-ask spreads and low trading volumes. This can make it difficult for investors to buy or sell shares quickly and efficiently, potentially leading to unfavorable pricing. The limited liquidity also increases the risk of price manipulation and volatility.
Factores de riesgo OTC:
  • Limited financial disclosure increases the risk of investing in CRWRF.
  • Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
  • Lack of regulatory oversight increases the risk of fraud and manipulation.
  • The OTC Other tier is associated with higher levels of risk compared to regulated exchanges.
  • Potential for limited or no information about the company's operations and financial condition.
Lista de verificación de diligencia debida:
  • Verify the company's legal status and registration.
  • Attempt to obtain and review any available financial statements.
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's regulatory compliance and risk management practices.
  • Understand the risks associated with investing in OTC Other securities.
  • Consult with a qualified financial advisor before making any investment decisions.
Señales de legitimidad:
  • Craneware plc is an established company with a history of operations.
  • The company has a market capitalization of $0.85 billion, suggesting a significant presence in the healthcare information services market.
  • Craneware has a dividend yield of 2.32%, indicating a commitment to returning value to shareholders.

Preguntas Comunes Sobre CRWRF

¿Cuáles son los factores clave para evaluar CRWRF?

Craneware plc (CRWRF) actualmente tiene una puntuación IA de 50/100, indicando puntuación moderada. Fortaleza clave: Comprehensive suite of software solutions for healthcare providers.. Riesgo principal a monitorear: Potential: Changes in healthcare regulations and reimbursement policies impacting demand for Craneware's solutions.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de CRWRF?

CRWRF actualmente puntúa 50/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de CRWRF?

Los precios de CRWRF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre CRWRF?

La cobertura de analistas para CRWRF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en CRWRF?

Las categorías de riesgo para CRWRF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changes in healthcare regulations and reimbursement policies impacting demand for Craneware's solutions.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de CRWRF?

La relación P/E para CRWRF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está CRWRF sobrevalorada o infravalorada?

Determinar si Craneware plc (CRWRF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de CRWRF?

Craneware plc (CRWRF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • AI analysis pending for CRWRF
  • OTC market data may have limited reliability.
Fuentes de datos

Popular Stocks